Hungarian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 46 displayed.
1 2 3 »

Sanofi: information concerning the total number of voting rights and shares, June 2019

Read more ››

By: Nasdaq / GlobenewsWire - 15 Jul 2019

Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma

Read more ››

By: Nasdaq / GlobenewsWire - 10 Jul 2019

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia

MELBOURNE, Australia, July 6, 2019 /PRNewswire/ -- The International Society on Thrombosis and... Read more ››

By: PR Newswire Association LLC. - 06 Jul 2019

Sanofi : Availability of the Pre-quarterly Results Communication

Read more ››

By: Nasdaq / GlobenewsWire - 02 Jul 2019

Sanofi : Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union

Read more ››

By: Nasdaq / GlobenewsWire - 01 Jul 2019

Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents

Read more ››

By: Nasdaq / GlobenewsWire - 28 Jun 2019

Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate

Read more ››

By: Nasdaq / GlobenewsWire - 27 Jun 2019

Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

Read more ››

By: Nasdaq / GlobenewsWire - 26 Jun 2019

Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma

Read more ››

By: Nasdaq / GlobenewsWire - 21 Jun 2019

Sanofi and Google to develop new healthcare Innovation Lab

Read more ››

By: Nasdaq / GlobenewsWire - 18 Jun 2019

Sanofi: information concerning the total number of voting rights and shares, May 2019

Read more ››

By: Nasdaq / GlobenewsWire - 17 Jun 2019

Soliqua® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments

Read more ››

By: Nasdaq / GlobenewsWire - 09 Jun 2019

Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer

Read more ››

By: Nasdaq / GlobenewsWire - 07 Jun 2019

Phase 3 trial of isatuximab combination therapy showed 40% reduction in the risk of disease progression or death for patients with relapsed/refractory multiple myeloma

Read more ››

By: Nasdaq / GlobenewsWire - 02 Jun 2019

Information concerning the total number of voting rights and shares

Read more ››

By: Nasdaq / GlobenewsWire - 21 May 2019

Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

Read more ››

By: Nasdaq / GlobenewsWire - 07 May 2019

Sanofi: Annual General Meeting of April 30, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 30 Apr 2019

Sanofi: FDA approves Praluent® (alirocumab) to prevent heart attack, stroke and unstable angina requiring hospitalization

Read more ››

By: Nasdaq / GlobenewsWire - 27 Apr 2019

ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes

Read more ››

By: Nasdaq / GlobenewsWire - 26 Apr 2019

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER

Read more ››

By: Nasdaq / GlobenewsWire - 26 Apr 2019

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

September 2019
- Boston: 9th Annual American Drug Delivery & Formulation Summit
- Malmo: NLS Days 2019
- Boston: Redefining Early Stage Investments (RESI)

Add an Event »

Latest company news

Sanofi: information concerning the total number of voting rights and shares, June 2019
15 Jul 2019 (Nasdaq / GlobenewsWire)

Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma
10 Jul 2019 (Nasdaq / GlobenewsWire)

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
06 Jul 2019 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The Hungarian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com